Why is Titan Biotech falling/rising?

As of 01-Aug, Titan Biotech Ltd's stock is currently priced at 428.00, reflecting an increase of 0.95, or 0.22%. The stock has shown a trend reversal by gaining after six consecutive days of decline, outperforming its sector by 2.18% today. Despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Over the past week, the stock has decreased by 4.04%, while it has gained 5.17% over the past month. However, the company has faced challenges, including negative results for the last three consecutive quarters and a significant decline in profits, which has contributed to a poor long-term growth outlook.
In the broader market context, the Sensex has decreased by 1.06% over the past week, suggesting that Titan Biotech's short-term performance is relatively better than the benchmark. However, the stock has underperformed the market over the last year, with a return of -26.97% compared to the Sensex's -1.55%. The company's high management efficiency, indicated by a return on equity of 25.08%, and a low debt-to-equity ratio may provide some support for the stock. Nonetheless, the expensive valuation relative to its peers, combined with declining profits, raises concerns about its future performance, contributing to the overall negative sentiment surrounding the stock.